News & Updates
Filter by Specialty:
Vedolizumab appears safe, effective in first-line treatment of ulcerative colitis in children
06 Jul 2022
Children with ulcerative colitis seem to respond well to vedolizumab in the first-line setting, inducing remission without increasing the risk of adverse events, according to a small study.
Vedolizumab appears safe, effective in first-line treatment of ulcerative colitis in children
06 Jul 2022
BTX-A safe, effective for kids with refractory OAB
03 Jul 2022
Children with refractory overactive bladder (OAB) benefit from botulinum toxin-A (BTX-A) injections, which can safely enlarge bladder and suppress OAB symptoms, a recent study has found.
BTX-A safe, effective for kids with refractory OAB
03 Jul 2022
Persistent ALT elevation triples risk of future T2D among overweight, obese children
30 Jun 2022
byJairia Dela Cruz
Children with overweight or obesity risk developing future type 2 diabetes (T2D) by threefold in the presence of persistent elevations in alanine aminotransferases (ALT), according to a study presented at the 54th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN 2022).